Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Taking a longer term view of cardiovascular risk: the causal exposure paradigm.

Publication ,  Journal Article
Sniderman, AD; Toth, PP; Thanassoulis, G; Pencina, MJ; Furberg, CD
Published in: Bmj
May 21, 2014

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Bmj

DOI

EISSN

1756-1833

Publication Date

May 21, 2014

Volume

348

Start / End Page

g3047

Location

England

Related Subject Headings

  • Risk Factors
  • Risk Assessment
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • General & Internal Medicine
  • Cardiovascular Diseases
  • Age Factors
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sniderman, A. D., Toth, P. P., Thanassoulis, G., Pencina, M. J., & Furberg, C. D. (2014). Taking a longer term view of cardiovascular risk: the causal exposure paradigm. Bmj, 348, g3047. https://doi.org/10.1136/bmj.g3047
Sniderman, Allan D., Peter P. Toth, George Thanassoulis, Michael J. Pencina, and Curt D. Furberg. “Taking a longer term view of cardiovascular risk: the causal exposure paradigm.Bmj 348 (May 21, 2014): g3047. https://doi.org/10.1136/bmj.g3047.
Sniderman AD, Toth PP, Thanassoulis G, Pencina MJ, Furberg CD. Taking a longer term view of cardiovascular risk: the causal exposure paradigm. Bmj. 2014 May 21;348:g3047.
Sniderman, Allan D., et al. “Taking a longer term view of cardiovascular risk: the causal exposure paradigm.Bmj, vol. 348, May 2014, p. g3047. Pubmed, doi:10.1136/bmj.g3047.
Sniderman AD, Toth PP, Thanassoulis G, Pencina MJ, Furberg CD. Taking a longer term view of cardiovascular risk: the causal exposure paradigm. Bmj. 2014 May 21;348:g3047.

Published In

Bmj

DOI

EISSN

1756-1833

Publication Date

May 21, 2014

Volume

348

Start / End Page

g3047

Location

England

Related Subject Headings

  • Risk Factors
  • Risk Assessment
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • General & Internal Medicine
  • Cardiovascular Diseases
  • Age Factors
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences